Concepedia

Wen-Hsing Wu

WW

Statistics

Publications

11

Citations

338

H-Index

10

Active since

2000

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Novartis (United States)

Novartis (Switzerland)

Wen-Hsing Wu is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2000–2023

11

Publications

11

Barbed sutures in facial rejuvenation

Wen-Hsing Wu · Aesthetic Surgery Journal · 2004 · 123 citations · Full text

Medicine, Maxillofacial Surgery, Surgery +11

C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.

Li Wang, Sue Lin, Wen-Hsing Wu et al. · PubMed · 2000 · 36 citations

Medicine, Molecular Biology, Oncology +8

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

Albert J. Farias, Wen-Hsing Wu, Xianglin L. Du · BMC Cancer · 2018 · 34 citations · Full text

Medicine, Endocrinology, Oncology +17

TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.

Wen-Hsing Wu, Jean‐Charles Soria, Luo Wang et al. · PubMed · 2001 · 33 citations

Life Sciences, Molecular Biology, Oncology +17

Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model

Wen-Hsing Wu, Joseph Celestino, Michael R. Milam et al. · International Journal of Gynecological Cancer · 2007 · 24 citations

Medicine, Oncology, Pharmacology +11

1–5 of 11